ZSAN stock forecast
Our latest prediction for Zosano Pharma Corp.'s stock price was made on the Feb. 27, 2018 when the stock price was at 8.29$.
In the short term (2weeks), ZSAN's stock price should underperform the market by -2.12%. During that period the price should oscillate between -15.33% and +24.54%.
In the medium term (3months), ZSAN's stock price should underperform the market by -1.17%. During that period the price should oscillate between -29.24% and +53.28%.Get email alerts
Create a solid portfolio with ZSAN
About Zosano Pharma Corp.
Zosano Pharma Corp. is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. The firm focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. It offers Qtrypta, a formulation of zolmitriptan delivered utilizing the intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -3.74$ per share.
The book value per share is 3.01$
Three months stock forecastFeb. 27, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|